NR APBC
AU Aguzzi,A.; Barbara,J.A.J.; Brown,P.; Budka,H.; Diringer,H.; Dormont,D.; Flanagan,P.; Heeschen,W.; Hope,J.; Hörnlimann,B.; Kenney,K.; Masters,C.; Macnaughton,M.R.; Pocchiari,M.; Rohwer,R.G.; Safar,J.G.; Somogyi,A.; Tateishi,J.; Taylor,D.M.; van Duijn,C.M.; Wilesmith,J.W.; Will,R.G.; Wisher,M.H.; Asher,D.M.; de Pedro Cuesta,J.; Feek,C.; Hasebe,K.; Horaud,F.; Löwer,J.; Minor,P.D.; Nandapalan,P.; Pavlov,A.; Perez,A.C.; Ricketts,M.N.; Vicari,G.; van Aken,W.G.; Beal,R.; Menache-Aronson,D.; Bradley,R.; Bailey,A.C.; Chalumeau,H.P.; Garland,A.; Brooks,W.; Schrieber,R.; Sprengers,E.; Andjaparidze,A.G.; Bolis,C.L.; Emmanuel,J.C.; Griffiths,E.; Heymann,D.L.; Kaboyo,W.; Meslin,F.X.; Miyagawa,S.; Padilla Marroquin,A.; Schudel,A.; Zeidler,M.
TI Medicinal and other products and human and animal transmissible spongiform encephalopathies - memorandum from a WHO meeting
QU Bulletin of the World Health Organization 1997; 75(N6): 505-13
PT Editorial
AB The report in March 1996 of 10 human cases of a novel form of Creutzfeldt-Jakob disease in the United Kingdom, and its possible link to the agent that causes bovine spongiform encephalopathy (BSE), raises many questions about the safety of animal-derived products and by-products entering the food chain or being used in medicine. This Memorandum updates the preventive measures put forward in 1991 to minimize the risks associated with the use of bovine-derived materials in medicinal products and medical devices.
ZR 10 Zitate
SP englisch